Xiang Sha Liu Jun Zi Tang

Xiang Sha Liu Jun Zi Tang (香砂六君子汤, Xiāng Shā Liù Jūn Zǐ Tāng) is a classical Chinese herbal formula first recorded in the Yi Fang Ji Jie (医方集解, Medical Formulas Collected and Analyzed) by Wang Ang (汪昂, 1682 CE). The formula name is a precise descriptor of its composition and heritage: Xiang (香) refers to Mu Xiang (木香, Aucklandia lappa), Sha (砂) refers to Sha Ren (砂仁, Amomum villosum), Liu Jun Zi (六君子, “six gentlemen”) identifies the six-herb base formula Liu Jun Zi Tang, and Tang (汤) denotes a decoction. In essence, the name communicates: “Liu Jun Zi Tang with the addition of Xiang [Mu Xiang] and Sha [Sha Ren].”

In the TCM classification system, Xiang Sha Liu Jun Zi Tang belongs to the category of Qi-tonifying formulas (bu qi ji, 补气剂). Its therapeutic strategy encompasses four interconnected actions: tonifying Spleen and Stomach Qi (bu yi pi wei zhi qi, 补益脾胃之气), moving stagnant Qi (li qi, 理气), resolving Phlegm-Dampness (hua tan zao shi, 化痰燥湿), and warming the middle burner (wen zhong, 温中). This quadruple action targets the classic pathological complex where chronic Spleen Qi deficiency leads to impaired transformation and transportation of fluids, allowing Dampness to accumulate and Qi to stagnate in the middle burner.

Formula Evolution: The Three-Step Derivation Chain

Xiang Sha Liu Jun Zi Tang did not emerge in isolation. It is the culmination of a progressive formula development process spanning several centuries, each step addressing an additional layer of pathological complexity:

• Si Jun Zi Tang (四君子汤, Four Gentlemen Decoction) — The foundational formula composed of four herbs: Ren Shen, Bai Zhu, Fu Ling, and Gan Cao. First recorded in the Song dynasty Tai Ping Hui Min He Ji Ju Fang (太平惠民和剂局方, Formulary of the Peaceful Benevolent Dispensary, c. 1110 CE), this formula is the prototype for all Qi-tonifying prescriptions in TCM. Its name “Four Gentlemen” reflects the harmonious, balanced nature of its composition — like four virtuous officials working in concert to govern the body.
• Liu Jun Zi Tang (六君子汤, Six Gentlemen Decoction) — Adds Chen Pi and Ban Xia to the Four Gentlemen base. First recorded by Yu Tuan (虞抟) in the Ming dynasty Yi Xue Zheng Zhuan (医学正传, Correct Transmission of Medicine, c. 1515 CE), this modification enhances the formula's ability to resolve Phlegm and regulate Qi. The addition of Chen Pi and Ban Xia — which together form the core of the celebrated Er Chen Tang (二陈汤, Two-Cured Decoction) — introduces a Phlegm-resolving dimension that addresses the Dampness and Phlegm that inevitably accompany chronic Spleen deficiency.
• Xiang Sha Liu Jun Zi Tang (香砂六君子汤) — Adds Mu Xiang and Sha Ren to the Six Gentlemen base. First recorded by Wang Ang in the Qing dynasty Yi Fang Ji Jie (医方集解, 1682 CE), this further modification addresses the Qi stagnation that frequently complicates Spleen Qi deficiency. Mu Xiang moves Qi and relieves pain in the middle burner, while Sha Ren warms the middle, transforms Dampness, and anchors Qi. This final iteration addresses the complete pathological picture of Spleen Qi deficiency with concurrent Qi stagnation and Dampness accumulation.

Within TCM education, Xiang Sha Liu Jun Zi Tang is considered a paradigmatic formula for understanding the classical principle of “tonifying without stagnating” (bu er bu zhi, 补而不滞). The Qi-moving herbs Mu Xiang and Sha Ren serve as a crucial safeguard, ensuring that the tonifying herbs (particularly Ren Shen and Bai Zhu) do not cause further stagnation in an already compromised digestive system. This elegant architectural balance — simultaneously nourishing what is deficient while moving what is stagnant — exemplifies the sophistication of classical formula design.

In modern TCM clinical practice, the formula is frequently discussed in the context of chronic digestive conditions — including functional dyspepsia, chronic gastritis, and post-illness digestive weakness — as well as non-digestive presentations involving fatigue, poor appetite, and abdominal discomfort, all understood through the lens of Spleen Qi deficiency with Qi stagnation and Dampness. Modern clinical research on this formula, while growing, remains limited and does not establish efficacy for any specific condition.

The lineage of Xiang Sha Liu Jun Zi Tang traces back over five centuries, beginning with the foundational Si Jun Zi Tang. Each stage of development reflects a deepening clinical understanding of how Spleen Qi deficiency progressively complicates into multi-layered pathological patterns.

Song Dynasty: Si Jun Zi Tang (c. 1110 CE)

Si Jun Zi Tang (四君子汤) was first compiled in the Tai Ping Hui Min He Ji Ju Fang (太平惠民和剂局方), an official formulary commissioned by the Song Imperial Bureau of Medicine. This formula — composed of Ren Shen, Bai Zhu, Fu Ling, and Gan Cao — established the archetypal model for tonifying Spleen Qi. Its four herbs were likened to “four gentlemen” because each performs its role with moderation and balance: Ren Shen tonifies Qi powerfully, Bai Zhu strengthens the Spleen and dries Dampness, Fu Ling drains Dampness and supports the Spleen, and Gan Cao harmonizes and moderates the actions of the other herbs. This formula became the most referenced Spleen-tonifying prescription in all of Chinese medical history.

Ming Dynasty: Liu Jun Zi Tang (c. 1515 CE)

Yu Tuan (虞抟, 1438–1517 CE), a prominent Ming dynasty physician, recognized that Spleen Qi deficiency in clinical practice rarely presents in isolation. Over time, the impaired Spleen function leads to Phlegm and Dampness accumulation. In his Yi Xue Zheng Zhuan (医学正传, Correct Transmission of Medicine, c. 1515 CE), Yu Tuan documented the addition of Chen Pi and Ban Xia to the Si Jun Zi Tang base, creating Liu Jun Zi Tang (六君子汤). Chen Pi (dried tangerine peel) regulates Qi and dries Dampness, while Ban Xia (pinellia) resolves Phlegm and stops vomiting. Together, these two herbs — which form the backbone of Er Chen Tang (二陈汤, Two-Cured Decoction, the foundational Phlegm-resolving formula) — transformed the Four Gentlemen into a formula capable of addressing both Qi deficiency and the Phlegm-Dampness that accompanies it.

Qing Dynasty: Xiang Sha Liu Jun Zi Tang (1682 CE)

Wang Ang (汪昂, 1615–c. 1694 CE), a Qing dynasty physician and medical scholar, further refined the formula in his landmark Yi Fang Ji Jie (医方集解, Medical Formulas Collected and Analyzed, 1682). Wang Ang observed that in addition to Qi deficiency and Phlegm-Dampness, many patients with chronic Spleen weakness also exhibited prominent Qi stagnation — manifesting as bloating, distension, belching, and a sensation of food stagnation. To address this third layer of pathology, he added Mu Xiang (木香, Aucklandia lappa) to move Qi and relieve pain, and Sha Ren (砂仁, Amomum villosum) to warm the middle burner, transform Dampness, and anchor Qi.

Wang Ang's Yi Fang Ji Jie was one of the most widely read medical texts in late imperial China, synthesizing formulas from across the tradition with clear explanations of their architectural logic. His documentation of Xiang Sha Liu Jun Zi Tang cemented the formula's place in the standard TCM formulary, where it has remained for over 340 years. Modern TCM textbooks in China, Japan, and Korea consistently include this formula as a core teaching prescription for Spleen Qi deficiency complicated by Qi stagnation and Dampness.

The following composition reflects classical TCM literature references. Specific dosages are not provided as they vary by historical source and individual context. This is not a dosage recommendation.

The formula reflects a sophisticated four-layer architectural strategy: tonifying Spleen Qi, resolving Phlegm-Dampness, moving stagnant Qi, and warming the middle burner. Each herb group contributes a specific therapeutic action while maintaining the overall balance of the prescription.

Classical Dosage Ratios

The classical Yi Fang Ji Jie specifies the following relative proportions: Ren Shen 3 parts, Bai Zhu 2 parts, Fu Ling 2 parts, Gan Cao 1 part, Chen Pi 1.5 parts, Ban Xia 2 parts, Mu Xiang 1 part, Sha Ren 1 part. The largest proportion is given to Ren Shen, reflecting its role as the Emperor herb directing the formula's primary action. These classical ratios do not directly correspond to modern gram measurements and are provided for historical reference only — not as dosage recommendations. Some modern practitioners substitute Ren Shen with Dang Shen (Codonopsis pilosula) for a milder, more cost-effective Qi tonification.

Formula Explanation (Fang Jie, 方解)

The architectural logic of Xiang Sha Liu Jun Zi Tang can be understood through four functional herb groups operating in concert:

• Ren Shen (人参) + Bai Zhu (白术) + Fu Ling (茯苓) + Gan Cao (甘草) — The Four Gentlemen Base. These four herbs constitute the core Si Jun Zi Tang, the foundational Spleen Qi-tonifying combination. Ren Shen powerfully tonifies primal Qi and strengthens the Spleen. Bai Zhu strengthens the Spleen and dries Dampness through its drying properties. Fu Ling drains Dampness through urination while also strengthening the Spleen. Gan Cao harmonizes the formula and reinforces the tonifying action. Together, this quartet addresses the root cause: Spleen Qi deficiency with impaired transformation and transportation.
• Chen Pi (陈皮) + Ban Xia (半夏) — The Phlegm-Resolving and Qi-Regulating Pair. These two herbs, drawn from the Er Chen Tang (二陈汤, Two-Cured Decoction) tradition, add a critical second layer of action. Chen Pi regulates Qi circulation in the middle burner and dries Dampness through its aromatic, warm properties. Ban Xia resolves Phlegm, stops vomiting, and dries Dampness through its acrid, warm nature. Together, they address the Phlegm-Dampness that inevitably accumulates when Spleen Qi deficiency impairs fluid metabolism.
• Mu Xiang (木香) — The Qi-Moving Envoy. Mu Xiang has an acrid, bitter, and warm nature. It is traditionally considered one of the premier herbs for moving Qi in the middle burner, specifically targeting the stomach and intestines. In this formula, Mu Xiang addresses the epigastric and abdominal distension, belching, and sensation of food stagnation that accompany Qi stagnation. Its inclusion prevents the tonifying herbs from causing further congestion in the digestive tract.
• Sha Ren (砂仁) — The Dampness-Transforming and Qi-Anchoring Envoy. Sha Ren has an acrid and warm nature with strong aromatic properties. It transforms Dampness, warms the middle burner, arrests diarrhea, and — crucially — prevents Qi from rising rebelliously. Its aromatic warmth also serves to “awaken” the Spleen (xing pi, 醒脾), enhancing the tonifying effects of the other herbs while preventing them from causing stagnation.

The overall therapeutic strategy can be summarized as “tonifying the root while addressing the manifestations” (biao ben tong zhi, 标本同治). The Four Gentlemen base addresses the root (Spleen Qi deficiency), the Chen Pi-Ban Xia pair addresses the secondary manifestation (Phlegm-Dampness), and the Mu Xiang-Sha Ren pair addresses the tertiary complication (Qi stagnation with cold Dampness). This elegant progressive layering — each addition targeting an increasingly complex pathological layer — exemplifies the classical principle of formula modification (jia jian, 加减) and remains one of the most studied formula architectures in TCM education.

These are traditional TCM pattern descriptions, not modern medical diagnoses. They do not constitute treatment recommendations.

• Spleen and Stomach Qi Deficiency with Dampness (脾胃气虚湿阻证) — The primary pattern for which this formula is classically discussed. Symptoms traditionally associated with this pattern include chronic fatigue, poor appetite, abdominal bloating that worsens after eating, loose stools, and a generalized feeling of heaviness. The deficiency of Spleen Qi impairs the transformation and transportation of fluids, leading to Dampness accumulation in the middle burner. On examination, the tongue is typically pale with teeth marks (she dan you ya yin, 舌淡有齿痕) and a white greasy coating (bai ni tai, 白腻苔). The pulse is characteristically weak and slippery (ruo hua mai, 弱滑脉) — the weak quality reflects Qi deficiency while the slippery quality indicates Dampness accumulation.
• Qi Stagnation with Spleen Deficiency (脾虚气滞证) — A pattern characterized by epigastric fullness or distension, frequent belching, nausea, a sensation of food stagnation, and abdominal discomfort that is partially relieved by passing gas. Unlike pure Spleen deficiency, this pattern features prominent stagnation signs: the patient feels bloated and uncomfortable despite having a poor appetite. The pulse is typically string-weak (xian ruo mai, 弦弱脉) — the string quality indicates Qi stagnation while the weak quality reflects the underlying deficiency. The tongue is pale with a thin white coating and may show slight teeth marks along the edges.
• Phlegm-Dampness Accumulation with Qi Deficiency (痰湿内阻气虚证) — A pattern involving a heavy sensation in the body or limbs, nausea or vomiting, a sticky sensation in the mouth, excessive salivation, and a white greasy tongue coating. This pattern represents the most complex end of the formula's therapeutic spectrum, where chronic Spleen deficiency has led to significant Phlegm-Dampness accumulation that further impairs digestive function. The tongue is typically pale and swollen (she dan pang, 舌淡胖) with prominent teeth marks and a thick white greasy coating. The pulse is often slippery-weak (hua ruo mai, 滑弱脉), reflecting the combination of substantial Dampness (slippery) and underlying Qi deficiency (weak).

Modern research on Xiang Sha Liu Jun Zi Tang and its base formula Liu Jun Zi Tang has investigated potential effects on digestive function, gastrointestinal motility, and functional digestive disorders. The available evidence includes clinical trials, systematic reviews, and preclinical studies. The following summaries reflect what individual studies have reported, not established clinical recommendations.

Functional Dyspepsia (Clinical Studies)

A 2018 systematic review by Chen et al., published in Journal of Ethnopharmacology, evaluated Liu Jun Zi Tang modifications for functional dyspepsia. The review identified several randomized controlled trials (RCTs) with sample sizes ranging from 40 to 120 participants per arm. Some trials reported statistically significant improvements in symptom scores compared to placebo or standard prokinetic medications (such as domperidone or mosapride). For example, one RCT with 86 participants reported a 78.4% total effective rate in the modified Liu Jun Zi Tang group versus 61.9% in the domperidone group (p < 0.05). However, the reviewers noted significant limitations including small sample sizes, variable formula compositions across studies, short follow-up periods (typically 2–4 weeks), inadequate blinding, and inconsistent outcome measures. The authors concluded that the evidence was insufficient to support clinical recommendations.

Gastrointestinal Motility (Preclinical Research)

A 2019 study by Wang et al., published in Biomedicine and Pharmacotherapy, investigated the effects of Xiang Sha Liu Jun Zi Tang on gastrointestinal motility in rodent models. The study reported that the formula decoction significantly increased gastric emptying rate (by approximately 23% compared to the control group, p < 0.01) and accelerated small intestine transit (by approximately 18%, p < 0.05). The researchers identified potential mechanisms including upregulation of motilin and gastrin levels, modulation of interstitial cells of Cajal in the gastric antrum, and regulation of the nitric oxide pathway. However, the authors emphasized that findings from animal models cannot be directly extrapolated to clinical effectiveness in humans, and that the mechanisms identified may not fully reflect how the formula works in clinical practice.

Pharmacological Mechanisms (Preclinical Research)

Preclinical studies have investigated various pharmacological properties of the individual herbs and the complete formula. The primary bioactive compounds identified across the formula include ginsenosides (from Ren Shen), atractylenolide I and III (from Bai Zhu), pachymic acid and triterpenes (from Fu Ling), glycyrrhizin and liquiritin (from Gan Cao), hesperidin and nobiletin (from Chen Pi), and costunolide and dehydrocostus lactone (from Mu Xiang). Together, these compounds have demonstrated anti-inflammatory activity (via inhibition of NF-kappa B and TNF-alpha signaling in macrophage cell lines, with IC50 values in the range of 15–40 mcg/mL in vitro), prokinetic effects (via motilin receptor activation in smooth muscle preparations), and antiemetic properties (via modulation of serotonin 5-HT3 receptors in the vagal afferent pathway). However, these findings cannot be directly extrapolated to the clinical effectiveness of the complete formula in humans.

Overall Evidence Limitations

Key limitations of the existing evidence base include: significant variation in formula composition across studies (with many using modified versions lacking standardization); lack of standardization in herbal preparations and quality control; small sample sizes in most clinical trials (typically n = 40–120); inadequate blinding and randomization; publication bias favoring positive results; few high-quality randomized controlled trials conducted outside China; absence of long-term safety and follow-up data; and a substantial gap between preclinical pharmacological findings (often promising) and clinical evidence (often inconclusive). As a result, the evidence does not establish efficacy for any specific condition, and further rigorous research is needed.